Patents by Inventor Cherl-Hyun Jeong

Cherl-Hyun Jeong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210054047
    Abstract: The present invention relates to a novel anticancer fusion protein and use thereof, and more particularly, provides a fusion protein in which a tumor necrosis factor (TNF) superfamily protein is linked to a self-assembled protein, which is capable of forming a protein nanocage by self-assembly of the self-assembled protein.
    Type: Application
    Filed: September 4, 2020
    Publication date: February 25, 2021
    Applicants: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY, KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Min-Woo KIH, Eun Jung LEE, Yoo Soo YANG, Cherl Hyun JEONG, In-San KIM, Soyoun KIM
  • Patent number: 10905774
    Abstract: The present invention relates to a novel recombinant nanocage and use thereof wherein the nanocage is formed by self-assembly of a fusion protein including a phagocytosis enhancing protein and a self-assembling protein, and to a protein nanocage complex in which an immunogenic cell death inducer is loaded in the nanocage as an active ingredient.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: February 2, 2021
    Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Gi Hoon Nam, Eun Jung Lee, Yoo Soo Yang, Cherl Hyun Jeong, In-San Kim, Kwangmeyung Kim
  • Publication number: 20190216947
    Abstract: The present invention relates to a novel recombinant nanocage and use thereof wherein the nanocage is formed by self-assembly of a fusion protein including a phagocytosis enhancing protein and a self-assembling protein, and to a protein nanocage complex in which an immunogenic cell death inducer is loaded in the nanocage as an active ingredient.
    Type: Application
    Filed: January 15, 2019
    Publication date: July 18, 2019
    Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Gi Hoon NAM, Eun Jung Lee, Yoo Soo Yang, Cherl Hyun Jeong, In-San Kim, Kwangmeyung Kim
  • Publication number: 20180028600
    Abstract: Provided is a recombinant exosome, and more specifically, to a recombinant exosome obtained from a eukaryotic cell transfected for the expression of a glucose transporter protein (GLUT) and a membrane fusogenic protein, and use thereof.
    Type: Application
    Filed: July 14, 2017
    Publication date: February 1, 2018
    Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Yeon-Sun HONG, Yoo Soo YANG, Cherl Hyun JEONG, In-San KIM
  • Patent number: 7776356
    Abstract: The present invention relates to a method for controlling the growth, size, and distribution of a lipid domain in a lipid layer using a substrate on which a topographic structure is formed, and a method of preparing a membrane device including a lipid layer having a lipid domain, where the growth, size, and distribution of the lipid domain can be controlled by said method, and a membrane device prepared thereby.
    Type: Grant
    Filed: March 26, 2007
    Date of Patent: August 17, 2010
    Assignees: Samsung SDI Co., Ltd., Seoul National University Industry Foundation
    Inventors: Sin-Doo Lee, Tae-Young Yoon, Cherl-Hyun Jeong, Sang-Wook Lee
  • Publication number: 20080033190
    Abstract: The present invention relates to a method for controlling the growth, size, and distribution of a lipid domain in a lipid layer using a substrate on which a topographic structure is formed, and a method of preparing a membrane device including a lipid layer having a lipid domain, where the growth, size, and distribution of the lipid domain can be controlled by said method, and a membrane device prepared thereby.
    Type: Application
    Filed: March 26, 2007
    Publication date: February 7, 2008
    Inventors: Sin-Doo Lee, Tae-Young Yoon, Cherl-Hyun Jeong, Sang-Wook Lee